susanna comi

PhD student in Molecular and Translational Medicine (DIMET Program) at CNLab from 2023. Susanna Comi received her master’s degree in Pharmaceutical Biotechnology in 2023 at University of Milano. The research activity of Susanna is aimed to validate PROPIMA (a MEK inhibitor) in vitro on different human melanoma cell lines in terms of cytotoxicity, mechanism of action and effect on migration. In addition to this, her work is focused on designing and validating liposomes able to incorporate and to deliver PROPIMA. 

Her expertise includes biochemistry, cellular  biology and liposomes preparation and characterization.